Last quarter (Q0 0), Telomir Pharmaceuticals, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Telomir Pharmaceuticals, Inc.'s net income was $-5.99M. See Telomir Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21
Total Revenue	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 8.43M	$ 3.94M	$ 854.15K	$ 138.13K
Operating Income	$ -8.43M	$ -3.97M	$ -854.15K	$ -138.13K
Net Non Operating Interest Income Expense	$ -716.24K	$ -1.64M	$ ―	$ ―
Other Income Expense	$ ―	$ 7.49M	$ ―	$ ―
Pretax Income	$ -9.15M	$ -13.10M	$ -854.15K	$ -138.13K
Tax Provision	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -9.15M	$ -13.07M	$ -854.15K	$ -138.13K
Basic EPS	$ -0.31	$ -0.48	$ -0.03	$ ―
Diluted EPS	$ -0.31	$ -0.45	$ -0.03	$ ―
Basic Average Shares	$ 88.83M	$ 27.30M	$ 29.61M	$ 29.61M
Diluted Average Shares	$ 88.83M	$ 29.02M	$ 29.61M	$ 29.61M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 8.43M	$ 3.94M	$ 854.15K	$ 138.13K
Net Income From Continuing And Discontinued Operation	$ -9.15M	$ -13.07M	$ -854.15K	$ -138.13K
Normalized Income	$ -7.37M	$ -10.35M	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―
EBIT	$ -7.44M	$ -11.46M	$ ―	$ ―
EBITDA	$ -7.44M	$ -9.85M	$ ―	$ ―

Currency in USD

Telomir Pharmaceuticals, Inc. Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing